Associacio Per A La Recerca Oncologica

Research activity is centered on non-muscle invasive bladder cancer, with attention to patients whose disease remains unresponsive to BCG treatment.

• Immune checkpoint therapy
• Antibody-drug conjugates
• High-risk non-muscle invasive disease

The sponsor’s bladder cancer work reflects interest in treatment options for localized urothelial malignancy where preserving bladder function and controlling recurrence are key clinical concerns.